608074171	608074171	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
62451179	62451179	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4737434	4737434	CD	B-NP	O
|	|	CC	I-NP	O
4/10/2006	4/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/14/2006	7/14/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NN	B-NP	O
:	:	:	O	O
MICHAELS	MICHAELS	NN	B-NP	O
,	,	,	O	O
TYRELL	TYRELL	NNP	B-NP	O
MERLIN	MERLIN	NNP	I-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Briefly	Briefly	NNP	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1976	1976	CD	B-NP	O
with	with	IN	B-PP	O
resultant	resultant	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
several	several	JJ	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

Catheterization	Catheterization	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Ville	Ville	NNP	I-NP	O
Tionsgon	Tionsgon	NNP	I-NP	O
County	County	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
in	in	IN	B-PP	O
Flint	Flint	NNP	B-NP	O
Ent	Ent	NNP	I-NP	O
Nyjer	Nyjer	NNP	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
known	know	VBN	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
OM	OM	NN	B-NP	O
and	and	CC	O	O
RCA	RCA	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
undergone	undergo	VBN	I-VP	O
a	a	DT	B-NP	O
SPECT	SPECT	NN	I-NP	O
thallium	thallium	NN	I-NP	O
scan	scan	NN	I-NP	O
2/3/06	2/3/06	CD	I-NP	O
in	in	IN	B-PP	O
Moineslumvale	Moineslumvale	NNP	B-NP	O
Ri	Ri	NNP	I-NP	O
Cons	Cons	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
anteroseptal	anteroseptal	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
anterior	anterior	JJ	B-NP	O
wall	wall	NN	I-NP	O
and	and	CC	O	O
apical	apical	JJ	B-NP	O
walls	wall	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
entirely	entirely	RB	I-VP	O
scarred	scar	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
viability	viability	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
scan	scan	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	ch	JJS	I-NP	O
CT	CT	NN	I-NP	B-protein
performed	perform	VBN	B-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2006	2006	CD	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
dilation	dilation	NN	I-NP	O
with	with	IN	B-PP	O
remodeling	remodel	VBG	B-VP	O
and	and	CC	O	O
calcified	calcify	VBN	B-VP	O
and	and	CC	I-VP	O
thinned	thin	VBN	I-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
past	past	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
nonsustained	nonsustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
dating	date	VBG	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
1983	1983	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
his	his	PRP$	B-NP	O
first	first	JJ	I-NP	O
AICD	AICD	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
at	at	IN	B-PP	O
Woodtwin	Woodtwin	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
PMC	PMC	NN	I-NP	B-cell_type
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate-sensing	rate-sensing	JJ	I-NP	O
lead	lead	NN	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
subclavian	subclavian	JJ	I-NP	O
vein	vein	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CPI	CPI	NNP	I-NP	O
mini	mini	NNS	I-NP	O
AICD	AICD	NNP	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
angina	angina	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
III	III	CD	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
marked	marked	JJ	B-NP	O
limitation	limitation	NN	I-NP	O
of	of	IN	B-PP	O
physical	physical	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
includes	include	VBZ	B-VP	O
also	also	RB	B-ADVP	O
diabetes	diabete	VBZ	B-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
and	and	CC	I-NP	O
gout	gout	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
past	past	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
in	in	IN	B-PP	O
80s	80	NNS	B-NP	O
and	and	CC	I-NP	O
ICD	ICD	NN	I-NP	O
placed	place	VBN	B-VP	O
via	via	IN	B-PP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
chest	chest	NN	I-NP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
,	,	,	O	O
replacement	replacement	NN	B-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
appendectomy	appendectomy	NN	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
inguinal	inguinal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
1986	1986	CD	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
eight-pack	eight-pack	JJ	I-NP	O
year	year	NN	I-NP	O
cigarette	cigarette	NN	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
intake	intake	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
drinks	drink	NNS	I-NP	O
per	per	IN	B-PP	O
month	month	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
formerly	formerly	RB	B-ADVP	O
a	a	DT	B-NP	O
dentist	dentist	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
allergies	allergy	NNS	I-NP	O
include	include	VBP	B-VP	O
erythromycin	erythromycin	NN	B-NP	O
giving	give	VBG	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
suspected	suspect	VBN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
toxicity	toxicity	NN	I-NP	O
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Valsartan	Valsartan	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Isosorbide	Isosorbide	NN	B-NP	B-protein
30	30	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
1.5	1.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Furosemide	Furosemide	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Coreg	Coreg	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Klonopin	Klonopin	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Glucophage	Glucophage	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
PHYSICAL	PHYSICAL	NNP	I-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
gentleman	gentleman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
5	5	CD	B-NP	O
feet	foot	NNS	I-NP	O
10	10	CD	B-NP	O
inches	inch	NNS	I-NP	O
and	and	CC	O	O
95	95	CD	B-NP	O
kg	kg	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
97.8	97.8	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
122/70	122/70	CD	B-NP	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
detectable	detectable	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Examination	Examination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
midline	midline	NN	I-NP	B-protein
sternotomy	sternotomy	NN	I-NP	I-protein
scar	scar	NN	I-NP	I-protein
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
healed	heal	VBN	I-VP	O
and	and	CC	O	O
an	an	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
were	be	VBD	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
equal	equal	JJ	I-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
scars	scar	NNS	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
right	right	JJ	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
quadrant	quadrant	JJ	I-NP	O
incision	incision	NN	I-NP	O
for	for	IN	B-PP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
ICD	ICD	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
without	without	IN	B-PP	O
scaring	scaring	NN	B-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
varicosities	varicosity	NNS	B-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Beauton	Beauton	NNP	I-NP	O
Geson	Geson	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Services	Services	NNP	I-NP	O
on	on	IN	B-PP	O
9/24/06	9/24/06	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	B-DNA
wire	wire	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

OPERATION	OPERATION	NN	B-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
6/16/06	6/16/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
Alfieri	Alfieri	NNP	I-NP	O
suture	suture	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CABG	CABG	NN	I-NP	B-protein
x3	x3	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Y-graft	Y-graft	JJ	I-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
;	;	:	O	O
SVG2	SVG2	NN	B-NP	B-protein
connects	connect	VBZ	B-VP	O
SVG1	SVG1	NN	B-NP	B-protein
to	to	TO	B-PP	O
LVB1	LVB1	NN	B-NP	B-protein
,	,	,	O	O
SVG1	SVG1	NN	B-NP	B-protein
connects	connect	VBZ	B-VP	O
to	to	TO	B-PP	O
aorta	aorta	NN	B-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
,	,	,	O	O
SVG3	SVG3	NN	B-NP	B-protein
to	to	TO	B-PP	O
ramus	ramus	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
repair	repair	NN	I-NP	O
and	and	CC	O	O
epicardial	epicardial	JJ	B-NP	O
lead	lead	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bypass	bypass	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
257	257	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cross-clamp	cross-clamp	JJ	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
98	98	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

ICU	ICU	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
propofol	propofol	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
adequately	adequately	RB	I-VP	O
sedated	sedate	VBN	I-VP	O
.	.	.	O	O

Sedation	Sedation	NN	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
Toradol	Toradol	NNP	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
Motrin	Motrin	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
p.o.s	p.o.	NNS	B-NP	O
and	and	CC	O	O
p.r.n.	p.r.n.	VB	B-VP	O
Morphine	Morphine	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Clonazepam	Clonazepam	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
neurologically	neurologically	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
ICU	ICU	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
,	,	,	O	O
moving	move	VBG	B-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
on	on	IN	B-PP	O
Neosynephrine	Neosynephrine	NN	B-NP	O
,	,	,	I-NP	O
epinephrine	epinephrine	NN	I-NP	O
and	and	CC	I-NP	O
milrinone	milrinone	NN	I-NP	O
drips	drip	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
milrinone	milrinone	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
weaning	wean	VBG	I-NP	O
trial	trial	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
mixed	mixed	JJ	I-NP	O
venous	venous	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
40s	40s	CD	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
50s	50	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
milrinone	milrinone	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
Neosynephrine	Neosynephrine	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
drip	drip	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
milrinone	milrinone	NN	B-NP	O
and	and	CC	I-NP	O
epinephrine	epinephrine	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
slowly	slowly	RB	I-VP	O
weaned	wean	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
epinephrine	epinephrine	NN	I-NP	O
coming	come	VBG	B-VP	O
off	off	RP	B-PRT	O
first	first	JJ	B-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
milrinone	milrinone	NN	I-NP	O
coming	come	VBG	B-VP	O
off	off	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
transiently	transiently	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
marginal	marginal	JJ	B-NP	O
mixed	mixed	JJ	I-NP	O
venous	venous	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
performance	performance	NN	I-NP	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
index	index	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
intraaortic	intraaortic	JJ	I-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
intraaortic	intraaortic	JJ	I-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
until	until	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
9	9	CD	I-NP	O
when	when	WRB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Slowly	Slowly	RB	B-ADVP	O
the	the	DT	B-NP	O
drips	drip	NNS	I-NP	O
were	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
afterload	afterload	JJ	I-NP	O
reducing	reduce	VBG	I-NP	O
agent	agent	NN	I-NP	O
,	,	,	O	O
first	first	RB	B-ADVP	O
a	a	DT	B-NP	O
drip	drip	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
nitroprusside	nitroprusside	NN	I-NP	O
,	,	,	O	O
after	after	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
esmolol	esmolol	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
esmolol	esmolol	NN	I-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
his	his	PRP$	B-NP	O
rates	rate	NNS	I-NP	O
slightly	slightly	RB	B-ADVP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
improve	improve	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
or	or	CC	O	O
his	his	PRP$	B-NP	O
mixed	mixed	JJ	I-NP	O
venous	venous	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
seem	seem	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
improvement	improvement	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
afterload	afterload	JJ	I-NP	O
reducing	reduce	VBG	I-NP	O
agent	agent	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
nitroprusside	nitroprusside	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
rapid	rapid	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
remained	remain	VBD	B-VP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
medical	medical	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
trial	trial	NN	B-NP	O
of	of	IN	B-PP	O
ibutilide	ibutilide	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
change	change	VB	I-VP	O
his	his	PRP$	B-NP	O
rate	rate	NN	I-NP	O
or	or	CC	O	O
convert	convert	VB	B-VP	O
him	him	PRP	B-NP	O
into	into	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
in	in	IN	B-PP	O
spite	spite	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
and	and	CC	I-NP	O
hepatic	hepatic	JJ	I-NP	O
toxicity	toxicity	NN	I-NP	O
with	with	IN	B-PP	O
plan	plan	NN	B-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
rate	rate	NN	I-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
convert	convert	VB	I-VP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
8	8	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
and	and	CC	O	O
cardioverted	cardioverte	VBD	B-VP	O
successfully	successfully	RB	B-ADVP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Transesophageal	Transesophageal	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
clots	clot	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
atrial	atrial	JJ	I-NP	O
ventricles	ventricle	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
11	11	CD	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
switched	switch	VBD	B-VP	O
back	back	RB	B-ADVP	O
into	into	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-VP	O
ibutilide	ibutilide	VB	I-VP	O
.	.	.	O	O

Attempted	Attempt	VBN	B-NP	O
cardioversion	cardioversion	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
failed	fail	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
better	well	RBR	B-ADJP	O
controlled	control	VBN	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80s	CD	I-NP	O
to	to	TO	B-PP	O
90s	90s	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
afterload-reducing	afterload-reducing	JJ	B-NP	O
agent	agent	NN	I-NP	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
and	and	CC	O	O
low-dose	low-dose	JJ	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
His	His	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
mixed	mixed	JJ	I-NP	O
venous	venous	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
50s	50s	CD	I-NP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADVP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
required	require	VBD	B-VP	O
BIPAP	BIPAP	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
needed	need	VBD	B-VP	O
an	an	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
his	his	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
but	but	CC	O	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
L	L	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
and	and	CC	O	O
get	get	VB	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
clear	clear	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
very	very	RB	B-NP	O
minimal	minimal	JJ	I-NP	O
p.o.	p.o.	NN	I-NP	O
's	'	VBZ	I-NP	O
because	because	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
BIPAP	BIPAP	NN	I-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
BIPAP	BIPAP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

Fecal	Fecal	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
Clostridium	Clostridium	NN	B-NP	O
difficile	difficile	NN	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
was	be	VBD	B-VP	O
resolving	resolve	VBG	I-VP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Diuril	Diuril	NNP	B-NP	O
boluses	bolus	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
aggressively	aggressively	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
remained	remain	VBD	B-VP	O
low	low	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
130s	130	NNS	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
off	off	RP	B-PRT	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
to	to	TO	B-VP	O
p.o.	p.o.	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
negative	negative	JJ	B-ADJP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
dose	dose	NN	B-NP	O
of	of	IN	B-PP	O
Synthroid	Synthroid	JJ	B-NP	O
initially	initially	RB	I-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
,	,	,	O	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
p.o.	p.o.	NN	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Portland	Portland	NNP	B-NP	O
protocol	protocol	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
initially	initially	RB	B-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
intraaortic	intraaortic	JJ	I-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	B-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
and	and	CC	O	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
heparin-induced	heparin-induced	JJ	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
argatroban	argatroban	NN	B-NP	O
and	and	CC	O	O
bridged	bridge	VBN	B-VP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
on	on	IN	B-PP	O
argatroban	argatroban	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
getting	get	VBG	I-VP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	B-protein
INR	INR	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
while	while	IN	B-SBAR	O
blood	blood	NN	B-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
ICU	ICU	NN	I-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
intraaortic	intraaortic	JJ	I-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
for	for	IN	B-PP	O
nine	nine	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
ID	ID	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
only	only	JJ	I-NP	O
positive	positive	JJ	I-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
coag-negative	coag-negative	JJ	I-NP	O
staph	staph	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
believe	believe	VBP	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
contaminant	contaminant	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
many	many	JJ	B-NP	O
days	day	NNS	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
gout	gout	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
flare	flare	VB	I-VP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
and	and	CC	O	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
colchicine	colchicine	NN	B-NP	O
and	and	CC	I-NP	O
Allopurinol	Allopurinol	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
following	follow	VBG	B-VP	O
medications	medication	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Clonazepam	Clonazepam	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
scales	scale	NNS	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Ambien	Ambien	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Darbepoetin	Darbepoetin	NN	B-NP	O
alfa	alfa	IN	B-PP	O
40	40	CD	B-NP	O
mcg	mcg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
and	and	CC	I-NP	O
NovoLog	NovoLog	NN	I-NP	B-protein
four	four	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
lunch	lunch	NN	B-NP	O
and	and	CC	O	O
six	six	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
dinner	dinner	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
continued	continued	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
and	and	CC	I-NP	O
occupational	occupational	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-7373774	5-7373774	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LUCKETT	LUCKETT	NNP	B-NP	O
,	,	,	O	O
JOSIAH	JOSIAH	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CIRCLE	CIRCLE	NNP	B-NP	O
,	,	,	O	O
CAREY	CAREY	NNP	B-NP	O
MITCH	MITCH	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3682207	3682207	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/1/06	5/1/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/1/06	5/1/06	CD	B-NP	O

